首页 | 本学科首页   官方微博 | 高级检索  
     


Cancer incidence in Iran in 2014: Results of the Iranian National Population-based Cancer Registry
Affiliation:1. Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran;2. Iranian National Population-Based Cancer Registry Secretariat, Cancer Office, Deputy of Health, Ministry of Health, Tehran, Iran;3. Cancer Office, Deputy of Health, Ministry of Health, Tehran, Iran;4. Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran;5. Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran;6. Pathobiology Laboratory, Bahman Hospital, Tehran, Iran;7. Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran;8. Chronic Disease Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran;9. Busher Cancer Registry, Busher University of Medical Sciences, Busher, Iran;10. Shahrekord Cancer Registry, Shahrekord University of Medical Sciences, Shahrekord, Iran;11. Torbateheidarieh Cancer Registry, Torbateheidarieh University of Medical Sciences, Torbate-heidarieh, Iran;12. Cancer Research Center, Cancer Registry Section, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran;13. Behbahan Cancer Registry, Behbahan University of Medical Sciences, Behbahan, Iran;14. Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran;15. Khorasan-North Cancer Registry, Khorasan-North University of Medical Sciences, Bojnord, Iran;p. Birjand Cancer Registry, Birjand University of Medical Sciences, Birjand, Iran;q. Arak Cancer Registry, Arak University of Medical Sciences, Arak, Iran;r. Qazvin Cancer Registry, Qazvin University of Medical Sciences, Qazvin, Iran;s. Center for Health Related Social and Behavioral Sciences Research, Shahroud University of Medical Sciences, Shahroud, Iran;t. Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran;u. Kermanshah Cancer Registry, Kermanshah University of Medical Sciences, Kermanshah, Iran;v. Bam Cancer Registry, Bam University of Medical Sciences, Bam, Iran;w. Department of Community Medicine, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran;x. Sabzevar Cancer Registry, Sabzevar University of Medical Sciences, Sabzevar, Iran;y. Gerash Cancer Registry, Gerash University of Medical Sciences, Gerash, Iran;z. Babol Cancer Registry, Babol University of Medical Sciences, Babol, Iran;1. Zahedan Cancer Registry, Zahedan University of Medical Sciences, Zahedan, Iran;2. Zanjan Cancer Registry, Zanjan University of Medical Sciences, Zanjan, Iran;3. Kashan Cancer Registry, Kashan University of Medical Sciences, Kashan, Iran;4. Dezfool Cancer Registry, Dezfool University of Medical Sciences, Dezfool, Iran;5. Khomein Cancer Registry, Khomein University of Medical Sciences, Khomein, Iran;6. Alborz Cancer Registry, Alborz University of Medical Sciences, Alborz, Iran;7. Lorestan Cancer Registry, Lorestan University of Medical Sciences, Lorestan, Iran;8. Abadan Cancer Registry, Abadan University of Medical Sciences, Abadan, Iran;9. Kerman Cancer Registry, Kerman University of Medical Sciences, Kerman, Iran;10. Saveh Cancer Registry, Saveh University of Medical Sciences, Saveh, Iran;11. Tehran Cancer Registry, Tehran University of Medical Sciences, Tehran, Iran;12. Fasa Cancer Registry, Fasa University of Medical Sciences, Fasa, Iran;13. Zabol Cancer Registry, Zabol University of Medical Sciences, Zabol, Iran;14. Iran University Cancer Registry, Iran University of Medical Sciences, Tehran, Iran;15. Iranshahr Cancer Registry, Iranshahr University of Medical Sciences, Iranshahr, Iran;P. Hamedan Cancer Registry, Hamedan University of Medical Sciences, Hamedan, Iran;Q. Urmia Cancer Registry, Urmia University of Medical Sciences, Urmia, Iran;R. Ilam Cancer Registry, Ilam University of Medical Sciences, Ilam, Iran;S. Torbatejam Cancer Registry, Torbatejam University of Medical Sciences, Torbatejam, Iran;T. Rafsanjan Cancer Registry, Rafsanjan University of Medical Sciences, Rafsanjan, Iran;U. Yasooj Cancer Registry, Yasooj University of Medical Sciences, Yasooj, Iran;V. Esfahan Cancer Registry, Esfahan University of Medical Sciences, Esfahan, Iran;W. Mashhad Cancer Registry, Mashhad University of Medical Sciences, Mashhad, Iran;X. Shiraz Cancer Registry, Shiraz University of Medical Sciences, Shiraz, Iran;Y. Guilan Cancer Registry, Guilan University of Medical Sciences, Rasht, Iran;Z. Jiroft Cancer Registry, Jiroft University of Medical Sciences, Jiroft, Iran;11. Hormozgan Cancer Registry, Hormozgan University of Medical Sciences, Hormozgan, Iran;12. Neishaboor Cancer Registry, Neishaboor University of Medical Sciences, Neishaboor, Iran;13. Gonabad Cancer Registry, Gonabad University of Medical Sciences, Gonabad, Iran;14. Maragheh Cancer Registry, Maragheh University of Medical Sciences, Maragheh, Iran;15. Esfarayen Cancer Registry, Esfarayen University of Medical Sciences, Esfarayen, Iran;16. Larestan Cancer Registry, Larestan University of Medical Sciences, Larestan, Iran;17. Semnan Cancer Registry, Semnan University of Medical Sciences, Semnan, Iran;18. Mazandaran Cancer Registry, Mazandaran University of Medical Sciences, Sari, Iran;19. Social Determinants of Health Research Center, Ardabil University of Medical Sciences, Ardebil, Iran;110. Jahrom Cancer Registry, Jahrom University of Medical Sciences, Jahrom, Iran;111. Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran;112. Osteoporosis Research center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran;113. Deputy Minister of Treatment, Ministry of Health, Tehran, Iran;114. Deputy Minister of Health, Ministry of Health, Tehran, Iran;1. Institute of Medical Epidemiology, Biostatistics and Informatics, Medical Faculty, Martin-Luther-University Halle-Wittenberg, Germany;2. Section of Cancer Information, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France;3. Department of Medicine, University of Zimbabwe School of Medicine, Harare, Zimbabwe;4. Department of Pathology, Maputo Central Hospital, Maputo, Mozambique;5. CTSU, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7FL, United Kingdom;6. African Cancer Registry Network, 267 Banbury Road, Oxford OX2 7HT, United Kingdom;1. School of Population and Public Health, University of British Columbia, Vancouver, Canada;2. Population Oncology, BC Cancer, Vancouver, Canada;3. Community Health Sciences, University of Manitoba, Winnipeg, Canada;4. Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada;1. Faculty of Medicine and Health Sciences, Department of Social Epidemiology and Health Policy, University of Antwerp, Belgium;2. Department of Oncology, Antwerp University Hospital, Antwerp, Belgium;3. Centre for Cancer Detection, Bruges, Antwerp, Belgium;4. Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO), University of Antwerp, Belgium;1. Department of Medicine, University of Kentucky, Lexington, KY, United States;2. Department of Neurology, University of Kentucky, Lexington, KY, United States;3. Departments of Neurosurgery, University of Kentucky, Lexington, KY, United States;4. Departments of Pathology, Division of Neuropathology, University of Kentucky, Lexington, KY, United States;5. Markey Cancer Center, University of Kentucky, Lexington, KY, United States;1. Department of Medical Sciences, Section of Dermatology and Infectious Diseases, University of Ferrara, Ferrara, Italy;2. Piacenza Cancer Registry, Local Health Unit, Piacenza, Italy;3. Parma Cancer Registry, University Hospital of Parma, Parma, Italy;4. Reggio Emilia Cancer Registry, Epidemiology Unit, Local Health Unit-IRCCS Reggio Emilia, Reggio Emilia, Italy;5. Modena Cancer Registry, Public Health Department, Local Health Unit Modena, Modena, Italy;6. Romagna Cancer Registry, Romagna Cancer Institute, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRST, IRCCS, Meldola, Forlì, Italy;7. Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara, Italy;8. Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Local Health Authority Ferrara, Ferrara, Italy;1. Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran;2. Department of Internal medicine, Sayyad Shirazi hospital, Golestan University of Medical Sciences, Gorgan, Iran;3. Cancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran;4. Department of Pathology, Sayyad Shirazi hospital, Golestan University of Medical Sciences, Gorgan, Iran;5. Deputy of Public Health, Golestan University of Medical Sciences, Gorgan, Iran;6. Death registry unit, Deputy of Public Health, Golestan University of Medical Sciences, Gorgan, Iran;7. Omid Cancer Research Center, Omid Preventive Medicine and Heath Promotion Center, Golestan University of Medical Sciences, Gorgan, Iran;8. Section for Cancer Surveillance, International Agency for Research in Cancer, Lyon, France;9. International Agency for Research in Cancer, World Health Organization, Lyon, France
Abstract:BackgroundWe aimed to report, for the first time, the results of the Iranian National Population-based Cancer Registry (INPCR) for the year 2014.MethodsTotal population of Iran in 2014 was 76,639,000. The INPCR covered 30 out of 31 provinces (98% of total population). It registered only cases diagnosed with malignant new primary tumors. The main sources for data collection included pathology center, hospitals as well as death registries. Quality assessment and analysis of data were performed by CanReg-5 software. Age standardized incidence rates (ASR) (per 100,000) were reported at national and subnational levels.ResultsOverall, 112,131 new cancer cases were registered in INPCR in 2014, of which 60,469 (53.9%) were male. The diagnosis of cancer was made by microscopic confirmation in 76,568 cases (68.28%). The ASRs of all cancers were 177.44 and 141.18 in male and female, respectively. Cancers of the stomach (ASR = 21.24), prostate (18.41) and colorectum (16.57) were the most common cancers in men and the top three cancers in women were malignancies of breast (34.53), colorectum (11.86) and stomach (9.44). The ASR of cervix uteri cancer in women was 1.78. Our findings suggested high incidence of cancers of the esophagus, stomach and lung in North/ North West of Iran.ConclusionOur results showed that Iran is a medium-risk area for incidence of cancers. We found differences in the most common cancers in Iran comparing to those reported for the World. Our results also suggested geographical diversities in incidence rates of cancers in different subdivisions of Iran.
Keywords:Cancer  Registries  Population surveillance  Iran
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号